Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes

Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes

Abstract Background Patients with type 2 diabetes (T2D) tend to have nonalcoholic fatty liver disease (NAFLD) with poorer prognosis. We performed this research to compare the risks of cardiovascular diseases, cirrhosis, liver-related mortality, and cardiovascular mortality between glucagon-like pept...

Full description

Bibliographic Details
Main Authors: Fu-Shun Yen, Ming-Chih Hou, James Cheng-Chung Wei, Ying-Hsiu Shih, Chii-Min Hwu, Chih-Cheng Hsu
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Medicine
Subjects:
All-cause mortality
Liver-related mortality
Cardiovascular mortality
Liver cirrhosis
Hepatic failure
Online Access:https://doi.org/10.1186/s12916-023-03228-4

Internet

https://doi.org/10.1186/s12916-023-03228-4

Similar Items